BOTSWANA – US-based medical device manufacturer, CTL Amedica Corporation, has signed a partnership agreement with the Ministry of Health & Wellness, and Sir Ketumile Masire Teaching Hospital (SKMTH) to establish a spinal and orthopedic devices manufacturing plant in the country.
The manufacturing plant which will be based on the grounds of the teaching hospital in Gaborone, will specifically focus on spine and orthopedic medical devices.
The MoHW Permanent Secretary Ms. Grace Muzila signed the partnership deal on behalf of the Government with the CTL Amedica President and Founder Mr Daniel Chon signing the deal on behalf of his company.
The MoHW intends to use the new initiative to reduce the cost of spines and orthopedic devices in the country, but also that of other implants and biomedical equipment in general.
The establishment of this plant will also position Botswana as a spine and orthopedic center of excellence.
Moreover, the MoHW hopes it will also help boost the country’s health tourism sector.
“The Ministry of Health is therefore, pleased to announce this historic development, which will help many Batswana receive specialized and top-notch health services, hitherto, uncommon in most developing countries,” the MoHW announced on its official social media accounts.
The Sir Ketumile Masire Teaching Hospital (SKMTH), also known as the University of Botswana Medical School, is the school of medicine of the University of Botswana, Botswana‘s oldest and largest public university.
On the other hand, CTL Amedica Corporation is a forward-thinking medical device design, development, and manufacturing company aiming to become the leader in medical device technologies and biomaterials.
Moreover, they design, manufacture, and support a full portfolio of spinal fusion and fixation products, including innovative surface technologies and exclusive biomaterials.
CTL Amedica maintains a Texas-based headquarters and in-house manufacturing facility, along with a Pennsylvania-based R&D Center of Excellence.
A leader in the medical device technology and biomaterials space, CTL Amedica provides a full line of cervical, thoracic, and lumbar fusion and fixation products.
Recently, it received clearance from the U.S. Food and Drug Administration (FDA) to market its NITRO Interbody Fusion Cage System Family.
The product is made entirely of the fusion biomaterial silicon nitride making CTL Amedica the world’s exclusive provider of silicon nitride spine products.
The new deal will make this CTL Amedica’s first foray into what it promises of many on the African continent.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
